Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed for two indications: (i) Phase 2b clinical study of enobosarm as a treatment to augment fat loss and to prevent muscle loss in sarcopenic obese or overweight elderly patients receiving a GLP-1 RA who are at-risk for developing muscle atrophy and muscle weakness and (ii) subject to the availability of sufficient funding, Phase 3 clinical trial of enobosarm for the treatment of androgen receptor positive (AR+), estrogen receptor positive (ER+) and human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer in the 2nd line setting. Sabizabulin, a microtubule disruptor, is being developed as a Phase 3 clinical trial for the treatment of hospitalized patients with viral-induced ARDS. The company was founded by William R. Gargiulo, Jr., O. B. Parrish, and Harry Fisch in 1971 and is headquartered in Miami, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
210
Frequently Asked Questions
What is Market Cap of Veru Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Veru Inc market cap is $56.58M.
What is the 52-week high for Veru Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Veru Inc 52 week high is $14.20 as of October 04, 2025.
What is the 52-week low for Veru Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Veru Inc 52 week low is $2.64 as of October 04, 2025.
What is Veru Inc stock price today?
Veru Inc stock price today is $3.80.
What was Veru Inc stock price yesterday?
Veru Inc stock price yesterday was $3.86.
What is the PE ratio of Veru Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Veru Inc’s P/E ratio is -1.98.
What is the Price-to-Book ratio of Veru Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Veru Inc P/B ratio is 3.6854.
What is the 50-day moving average of Veru Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Veru Inc 50-day moving average is $3.81.